High expression of TM4SF1 predicted a poor prognosis in patients with glioma, colorectal cancer, breast cancer, papillary thyroid carcinomas and ovarian cancer but predicted good prognosis in GC, pancreatic cancer, breast cancer and MPM. This evidence concerns the gene TM4SF1 and ovarian carcinoma.